SRX Global Inc.

SRXH
About the company

SRX Global Inc. operates an AI-driven platform focused on generating long-term shareholder value through investments in high-conviction operating companies, strategic assets, and technology-enabled opportunities. It leverages proprietary technology, data analytics, and disciplined capital allocation to identify and manage investments across various sectors. The company is based in Tampa, Florida.

Country: United StatesPrice: $0.95Market Cap: $19.2M

Investment snapshot

12%positive consensus
Scored 1d ago

Positive

2

BUY / PASS

Neutral / negative

1 / 13

NEUTRAL / FAIL

Median fair value

—

No comparable estimates

Models with upside

0 / 17

Positive margin of safety

Strongest signal

10 of 12 pass — Buffett and Marks object

Key risk

No clean pass — all 13 investors flag at least one valuation criterion

Framework analysis

VerdictMeaning
BUYPositive purchase signal: the framework's buy requirements are met.
PASSThe company clears the framework's checklist or screen, but the framework does not produce a buy signal. For valuation frameworks this often means margin of safety is missing, insufficient, or unavailable; some screen-only frameworks have no intrinsic-value BUY state.
NEUTRALNeither a positive nor negative conclusion. It does not mean to hold an existing position.
FAILThe company does not clear the framework's requirements.
RankedRanked strategies do not use PASS: selected cohort is BUY, outside the cohort is FAIL, and unranked is NEUTRAL.

Current investor scores use trailing 12-month flows and the latest balance sheet where supported. Multi-year and EPS tests retain annual history; each framework shows its financial basis below. Intrinsic values use annual financials.

MetricGraham

Defensive Value

Buffett

Quality Compounder

Lynch

GARP

Greenblatt

Magic Formula

Piotroski

F-Score

Dreman

Contrarian Value

Munger

Quality Focus

Pabrai

Dhandho Framework

Akre

Three-Legged Stool

Marks

Risk-Aware Value

Ackman

Activist Value

Templeton

Global Bargain Hunter

Sleep

Scale Economies Shared

Asness

Systematic Factors

Neff

Low-P/E Total Return

Schloss

Asset-Value Discipline

O'Shaughnessy

Systematic Factor Composite

VerdictFAILFAILFAILNot rankedFAILFAILPASSFAILFAILFAILFAILPASSFAILFAILFAILFAILNEUTRAL
Score
AnalysisChecking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…
Intrinsic Value (annual)N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Margin of SafetyN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Financial Basis

TTM ended 2026-06-30 · Balance sheet at 2026-06-30 · Annual history · FY 2025

Latest source filing: 2026-08-13

Score computed: 2026-11-14

Annual history · FY 2025

Latest source filing: 2025-12-05

Score computed: 2026-11-14

Annual history · FY 2025 · Balance sheet at 2026-06-30 · TTM ended 2026-06-30

Latest source filing: 2026-08-13

Score computed: 2026-11-14

TTM ended 2026-06-30

Latest source filing: 2026-08-13

Score computed: 2026-11-14

Annual history · FY 2025

Latest source filing: 2025-12-05

Score computed: 2026-11-14

Annual history · FY 2025 · TTM ended 2026-06-30 · Balance sheet at 2026-06-30 · Market data at 2026-11-01

Latest source filing: 2026-08-13

Score computed: 2026-11-14

Qualitative assessment · Annual history · FY 2025 · TTM ended 2026-06-30 · Balance sheet at 2026-06-30

Latest source filing: 2026-08-13

Score computed: 2026-11-14

Qualitative assessment · Annual history · FY 2025

Latest source filing: 2025-12-05

Score computed: 2026-11-14

Annual history · FY 2025 · Qualitative assessment · Balance sheet at 2026-06-30

Latest source filing: 2026-08-13

Score computed: 2026-11-14

Annual history · FY 2025 · Qualitative assessment

Latest source filing: 2025-12-05

Score computed: 2026-11-14

Annual history · FY 2025 · TTM ended 2026-06-30 · Balance sheet at 2026-06-30 · Market data at 2026-11-01

Latest source filing: 2026-08-13

Score computed: 2026-11-14

Annual history · FY 2025 · Price history 2025-01-01–2026-11-01 · Balance sheet at 2026-06-30

Latest source filing: 2026-08-13

Score computed: 2026-11-14

Annual history · FY 2025 · Qualitative assessment

Latest source filing: 2025-12-05

Score computed: 2026-11-14

TTM ended 2026-06-30 · Balance sheet at 2026-06-30 · Price history 2025-01-01–2026-11-01 · Annual history · FY 2025

Latest source filing: 2026-08-13

Score computed: 2026-11-14

Annual history · FY 2025

Latest source filing: 2025-12-05

Score computed: 2026-11-14

Annual history · FY 2025 · Balance sheet at 2026-06-30

Latest source filing: 2026-08-13

Score computed: 2026-11-14

TTM ended 2026-06-30 · Annual history · FY 2025 · Price history 2025-01-01–2026-11-01

Latest source filing: 2026-08-13

Score computed: 2026-11-14

Where It Passes

  • Debt & Leverage83% pass✓ 13✗ 2▾

    10 of 12 pass — Buffett and Marks object

    LT Debt vs Net Current AssetsLT Debt $0.0M vs NCA $62.9M
    ✓GrahamLT Debt <= Net Current Assets
    Debt/Equity & Interest CoverageD/E: 10.94, IC: -18.2x
    ✗BuffettD/E < 0.5 AND Interest Coverage > 5x
    Total Debt / Equity0
    ✓Lynch< 0.33
    Cash - Long-term Debt$35.2M
    ✓LynchPositive preferred
    LT Debt / Total Assets Change2.06% -> 0.00%
    ✓PiotroskiDecreased YoY
    Current Assets / Current Liabilities27.55
    ✓Dreman> 1.5✓SchlossCurrent ratio >= 1.50x (app cutoff)
    Total Debt / Shareholders' Equity0
    ✓Dreman< 0.8✓Templeton< 1.0 (fixed cap; proxy for below-sector-median leverage)✓SchlossD/E < 1.00x
    Debt Levels0
    ✓MungerDebt/Equity < 0.5✓AkreDebt/Equity < 0.3
    Interest Coverage & Debt/EBITDAIC=-18.2x, D/EBITDA=N/A
    ✗MarksInterest Coverage > 3x; Debt/EBITDA < 4x
    Total Debt / Shareholders Equity0
    ✓Ackman<= 1.0
    Negative debt-to-equity (higher means less debt)-0.0000; #1/4210 (top 0.0%)
    ✓AsnessTop 30% of eligible cross-section

Where It Falls Short

  • Valuation0% pass✓ 2✗ 26▾

    No clean pass — all 13 investors flag at least one valuation criterion

    Price / 3-yr avg EPS
    ✗Graham<= 15x
    Price-to-Book Ratio58.3x
    ✗Graham<= 1.5x
    P/E x P/B
    ✗Graham<= 22.5
    Basic earnings-growth PEG (dividends excluded)
    ✗Lynch< 1.0 (ideally < 0.5)
    EBIT / Enterprise ValueN/A (EV <= 0)
    ✗Greenblatt> 10%
    Earnings Yield + ROC AssessmentEY=N/A (EV <= 0), ROC=43.2%
    ✗GreenblattBoth EY > 10% and ROC > 25%
    Price / EPS
    ✗Dreman< 12x✗Templeton< 12x (fixed ceiling; proxy for the market's cheapest 40%)
    Price / (CFO / Shares)N/A (negative CFPS)
    ✗Dreman< 8x
    Price / Book Value per Share58.3x
    ✗Dreman< 1.2x✗Templeton< 1.5x✗SchlossP/B <= 0.80x (app cutoff)
    Valuation ReasonablenessOE Yield=-189.6%
    ✗MungerP/E < 25 or Owner Earnings Yield > 5%
    P/E or FCF Yield
    ✗PabraiP/E < 15 or FCF Yield > 10%
    P/B or P/E vs. Historical AverageP/B=58.3x
    ✗MarksP/E < 15 or P/B < 2.0
    Discount to Intrinsic Value
    ✗Marks>= 20% below intrinsic value
    Price / FCF per Share
    ✗Ackman<= 25
    Price vs. Trailing Low100% of trailing low ($0.95)
    ✓Templeton<= 120% of trailing low (certified split-adjusted live window)
    Net income / market capitalization-179.04%; #5629/6340 (top 88.8%)
    ✗AsnessTop 30% of eligible cross-section✗OshaughnessyTop 10% of eligible cross-section
    Positive book equity / market capitalization+7.4429; #223/6449 (top 3.5%)
    ✓AsnessTop 30% of eligible cross-section
    Price / Diluted EPS
    ✗NeffP/E <= 15x (app proxy for a P/E 40%-60% below the market)
    (EPS CAGR % + Dividend Yield %) / P/E
    ✗Neff> 0.7 (Neff's published traditional edge)
    Price / Tangible Book Value per Share58.28x
    ✗SchlossP/TBV <= 1.00x (app cutoff)
    Book Value per Share Change
    ✗SchlossLatest BVPS >= earliest BVPS over >= 3 years (app rule)
    Revenue / market capitalization-1.2966; #5243/5247 (top 99.9%)
    ✗OshaughnessyTop 10% of eligible cross-section
    (Operating cash flow - capex) / market capitalization
    ✗OshaughnessyTop 10% of eligible cross-section
    Trailing six-month price return through the evaluation date-87.60%; #5952/6202 (top 96.0%)
    ✗OshaughnessyTop 10% of eligible cross-section
  • Cash Flow0% pass✓ 1✗ 11▾

    No clean pass — all 10 investors flag at least one cash flow criterion

    Free Cash Flow Proxy$-38.7M
    ✗BuffettPositive and growing
    FCF Positive and Growing$-1.5M
    ✗LynchPositive and growing
    Operating Cash Flow$-8.1M
    ✗PiotroskiCFO > 0
    (CFO / Total Assets) vs ROACFO/Assets=-96.92%, ROA=-535.66%
    ✓PiotroskiCFO/Assets > ROA
    Price / (CFO / Shares)N/A (negative CFPS)
    ✗Dreman< 8x
    P/E or FCF Yield
    ✗PabraiP/E < 15 or FCF Yield > 10%
    FCF Positive1/10 years FCF positive
    ✗MarksPositive FCF in majority of recent years
    (OCF - CapEx) / Market Cap
    ✗Ackman>= 4%
    Price / FCF per Share
    ✗Ackman<= 25
    Positive Operating Cash Flow frequency1/15 years positive
    ✗SleepPositive OCF in >= 70% of available years
    Operating Cash Flow - Capital Expenditures
    ✗Neff> $0 (app proxy for a strong fundamental case)
    (Operating cash flow - capex) / market capitalization
    ✗OshaughnessyTop 10% of eligible cross-section
  • Growth0% pass✓ 1✗ 12▾

    No clean pass — all 8 investors flag at least one growth criterion

    EPS Growth (3-yr avg, 10-yr window)
    ✗Graham>= 33% growth
    Basic earnings-growth PEG (dividends excluded)
    ✗Lynch< 1.0 (ideally < 0.5)
    3-5 Year EPS CAGR
    ✗Lynch15-30% (Fast Grower); > 0% to pass
    Inventory Growth vs Revenue GrowthInv: -38.3% vs Rev: -81.3%
    ✗LynchInventory growth < Revenue growth
    EPS Growth Direction
    ✗DremanPositive over recent years
    EPS CAGR
    ✗Dreman> 5% annualized
    Positive Net Income Frequency1/18 years positive
    ✗MarksPositive net income in >= 7 of last 10 years
    3yr Median Revenue Growth-81.3%
    ✗Ackman>= 5%
    Positive EPS Growth Frequency
    ✗AckmanPositive EPS growth in >= 3 of last 5 years
    5-Year EPS CAGR
    ✗Templeton> 0% (5-year EPS CAGR)
    Revenue growth vs. gross and operating margin trendgross margin 589.9% -> 23.4%, operating margin -1058.9% -> -174.6%
    ✓SleepRevenue rising; gross margin flat or falling; operating margin holding
    5-year Revenue CAGR-31.3%
    ✗SleepCAGR > 7%
    3-5 Year Diluted EPS CAGR
    ✗Neff7%-20% annualized
  • Profitability6% pass✓ 4✗ 31▾

    15 of 16 flag SRXH's profitability — Graham, Buffett, Lynch +12 more

    Positive EPS (10 years)1/18 years positive
    ✗GrahamPositive EPS every year for 10 years
    EPS Growth (3-yr avg, 10-yr window)
    ✗Graham>= 33% growth
    Net Income Positive (10+ years)1/18 years positive
    ✗BuffettPositive every year for 10+ years
    ROE (up to 5-year arithmetic mean)-3101.7%
    ✗Buffett> 15% arithmetic mean (app rule)
    Operating Margin (10-yr trend)-174.6% (latest)
    ✓BuffettStable or rising over 10 years
    Free Cash Flow Proxy$-38.7M
    ✗BuffettPositive and growing
    Earnings Variance (10-yr CoV)
    ✗BuffettCoV < 0.3
    Retained Earnings Effectiveness
    ✗Buffett$1 retained -> > $1 market value created
    Basic earnings-growth PEG (dividends excluded)
    ✗Lynch< 1.0 (ideally < 0.5)
    3-5 Year EPS CAGR
    ✗Lynch15-30% (Fast Grower); > 0% to pass
    ROE-24.1%
    ✗Lynch> 15%
    EBIT / Enterprise ValueN/A (EV <= 0)
    ✗Greenblatt> 10%
    Earnings Yield + ROC AssessmentEY=N/A (EV <= 0), ROC=43.2%
    ✗GreenblattBoth EY > 10% and ROC > 25%
    Net Income / Total Assets-535.66%
    ✗PiotroskiROA > 0
    ROA Change YoY-127.51% -> -535.66% (delta: -408.14%)
    ✗PiotroskiCurrent ROA > Prior ROA
    (CFO / Total Assets) vs ROACFO/Assets=-96.92%, ROA=-535.66%
    ✓PiotroskiCFO/Assets > ROA
    Gross Margin Change YoY37.1% -> 23.4%
    ✗PiotroskiImproved YoY
    Pre-Tax Income / Revenue-10.5%
    ✗Dreman>= 8%
    Net Income / Shareholders' Equity-24.1%
    ✗Dreman> 12%
    Margin of SafetyP/B=58.3x
    ✗PabraiP/B < 1.5 or P/E < 15
    Return on Equity-3744.9% (3-yr avg)
    ✗AkreROE > 20% (3-year avg)
    Discount to Intrinsic Value
    ✗Marks>= 20% below intrinsic value
    Positive Net Income Frequency1/18 years positive
    ✗MarksPositive net income in >= 7 of last 10 years
    Operating Income / Revenue-48.0%
    ✗Ackman>= 15%
    Net Income / Shareholders Equity-24.1%
    ✗Ackman>= 15%
    5-Year EPS CAGR
    ✗Templeton> 0% (5-year EPS CAGR)
    Operating Margin Trend-1058.9% (2023) -> -174.6% (2025)
    ✓TempletonNon-negative operating-margin trend over 3 years
    Revenue growth vs. gross and operating margin trendgross margin 589.9% -> 23.4%, operating margin -1058.9% -> -174.6%
    ✓SleepRevenue rising; gross margin flat or falling; operating margin holding
    Net income / market capitalization-179.04%; #5629/6340 (top 88.8%)
    ✗AsnessTop 30% of eligible cross-section✗OshaughnessyTop 10% of eligible cross-section
    Gross profit / total assets-3.81%; #3608/3702 (top 97.5%)
    ✗AsnessTop 30% of eligible cross-section
    Net income / positive book equity-24.05%; #3778/5226 (top 72.3%)
    ✗AsnessTop 30% of eligible cross-section
    Negative 5-year standard deviation of ROA-1.8513; #5441/5884 (top 92.5%)
    ✗AsnessTop 30% of eligible cross-section
    3-5 Year Diluted EPS CAGR
    ✗Neff7%-20% annualized
    Positive Diluted-EPS Years1/10 years positive
    ✗Schloss>= 70% positive over 5-10 observed years (app rule)
  • Verdicts13% pass✓ 2✗ 13▾

    Split decision: 13 FAIL · 2 PASS · 1 NEUTRAL

    Overall verdict
    ✗GrahamFAIL (2/9)✗BuffettFAIL (1/9)✗LynchFAIL (2/7)•GreenblattNot ranked✗PiotroskiFAIL (F-Score 3)✗DremanFAIL (2/11)✓MungerPASS (2/4)✗PabraiFAIL (0/3)✗AkreFAIL (1/6)✗MarksFAIL (0/5)✗AckmanFAIL (2/9)✓TempletonPASS (4/8)✗SleepFAIL (2/6)✗AsnessFAIL (Rank #2083/2370 (Top 87.9%))✗NeffFAIL (0/6)✗SchlossFAIL (2/7)•OshaughnessyNEUTRAL (Not ranked)
  • Efficiency38% pass✓ 4✗ 7▾

    5 of 8 flag SRXH's efficiency — Buffett, Piotroski, Munger +2 more

    Current Ratio27.55
    ✓Graham>= 2.0
    ROIC (3-5 yr avg)-838.3%
    ✗Buffett> 10%
    ROIC - WACC-848.3%
    ✗BuffettPositive (WACC = 10%)
    EBIT / (NWC + Net Fixed Assets)43.2%
    ✓Greenblatt> 25%
    Current Ratio Change YoY0.17 -> 2.29
    ✓PiotroskiIncreased YoY
    Revenue / Total Assets Change YoY1.04x -> 0.78x
    ✗PiotroskiImproved YoY
    Current Assets / Current Liabilities27.55
    ✓Dreman> 1.5
    Return on Invested Capital6.6%
    ✗Munger> 15%
    ROIC (high and growing)FY2023: ROIC=unavailable; FY2024: ROIC=unavailable; FY2025: ROIC=-185.4%
    ✗AkreLatest 3 consecutive FYs: ROIC > 15% in each
    Reinvestment Rate x ROICN/A (non-positive net income)
    ✗AkreReinvestment Rate * ROIC > 10%
    ROIC (5-year)0/3 years above 12% (latest -185.4%)
    ✗SleepROIC > 12% in a majority of years

Business & financials

Financial snapshot: annual FY 2025. Current investor scores may use newer quarterly data.

Company Profile

Industry: Beer & Liquor
SIC Sector: Food Products
Size: Micro Cap($19.2M)
Revenue: $6.5M-81.3% YoY
Net Income: $45.0M-4.5% YoY

Financial Snapshot

Operating Margin-174.6%
Return on Equity-11058.0%
Debt / Equity10.94
Current Ratio2.29
EPS (Diluted)$-2.13
Buybacks (1y)$137.0K
Buybacks (2y)$343.0K

Similar Companies

KOCOCA COLA CO
$427.0B
PEPPEPSICO INC
$198.2B
BUDAnheuser-Busch InBev SA/NV
$167.0B
DEODIAGEO PLC
$56.6B

Shareholder Return

Fiscal 2025

Share retirement not available for this company.

Buybacks
$137.0K
Dividends
—

Company Financials

Latest TTM and quarters alongside annual years

TTM sums four consecutive quarters and uses the latest quarter-end balances. Quarter columns show three-month results; annual columns show full-year totals. Growth compares the same period a year earlier. EPS is not added for TTM; full-year ratios are blank for quarters.

The latest annual period end is unavailable. Showing the latest fiscal cycle’s quarters; quarter and annual columns may overlap. Quarterly shows the full quarter history.

MetricTTM · 2026-06-30

2025-07-01 – 2026-06-30

Sources · derived quarter values

Derived from cumulative filings: revenue, net income, operating income, gross profit, ebit, pre tax income, operating cash flow, depreciation amortization, buybacks.

Q3 FY 2026

2026-04-01 – 2026-06-30

Sources · derived quarter values

Derived from cumulative filings: buybacks.

Q2 FY 2026

2026-01-01 – 2026-03-31

Sources · derived quarter values

Derived from cumulative filings: operating cash flow.

Q1 FY 2026

2025-10-01 – 2025-12-31

Sources
FY 2025
Sources
  • 10-K · 2025-12-05
FY 2024
Sources
  • 10-K · 2025-12-05
FY 2023
Sources
  • 10-K · 2024-04-12
FY 2022
Sources
  • 10-K · 2023-03-28
FY 2021
Sources
  • 10-K · 2022-03-29
Market Cap$19.2Mcurrent------$3.4Mest.--$4.5Mest.$645.3Mest.$2.0Best.
Revenue-$24.9M$3.4M↓70%$3.4M$2.8M$6.5M↓81%$35.0M↑1649%$2.0M↓96%$54.7M↑19%$46.0M
Operating Income$12.0M-$3.2M↑82%-$1.8M-$3.8M-$11.4M↓91%-$6.0M↑72%-$21.2M↑45%-$38.8M↓124%-$17.3M
Net Income-$34.4M-$4.1M↑73%-$6.4M-$8.6M-$45.0M↓5%-$43.1M↓89%-$22.8M↑42%-$39.3M↓1261%$3.4M
EPS (Diluted)--$-0.36↑51%$-0.02$-0.26$-2.13↓2030%$-0.10↑100%$-32.29↓2310%$-1.34↓1057%$0.14
Gross Margin22.2%26.7%↓11%37.1%37.5%23.4%↓37%37.1%↓94%589.9%↑2013%27.9%↓16%33.4%
Operating Margin-48.0%-94.4%↑38%-52.9%-135.0%-174.6%↓923%-17.1%↑98%-1058.9%↓1392%-71.0%↓89%-37.6%
ROE-24.1%———-11058.0%↓14257%78.1%↑16%67.4%↑137%-182.6%↓3221%5.9%
Total Debt$0$0↓100%$22.6M$21.0M$4.5M↓86%$32.3M↑598%$4.6M↓60%$11.4M↑11%$10.3M
Shareholders' Equity$143.0M$143.0M↑412%$18.3M$3.5M$407.0K↑101%-$55.1M↓63%-$33.8M↓257%$21.5M↓63%$57.9M
Current Ratio27.5527.55↑8225%1.720.802.29↑1267%0.17↓86%1.19↓76%4.93↓18%5.98
Debt / Equity0.000.00↑100%1.245.9710.94↑1968%-0.59↓328%-0.14↓126%0.53↑200%0.18
Operating Cash Flow-----$6.6M-$2.9M-$8.1M↓451%-$1.5M↓1624%$97.0K↑100%-$20.6M↓73%-$11.9M
Free Cash Flow-----------$1.5M↓2023%$79.0K↑100%-$20.8M↓70%-$12.2M

Score history

Historical Score Timeline

Industry peers

Industry Peers

Similar companies in Beer & Liquor

SRXH vs Peers — Financial Grading

Revenue$6.5MBottom 25%
Net Income$45.0MBottom 25%
ROE-11058.0%Bottom 25%
D/E10.94Bottom 25%
Op. Margin-174.6%Bottom 25%
Curr. Ratio2.29Top 25%
CompanyMarket CapPriceRevenueNet IncomeROED/EOp. MarginCurr. RatioGrahamBuffettLynchGreenblattPiotroskiDreman
COCA COLA COKO$427.0B$99.25$47.9B$13.1B40.7%1.3728.7%1.463/96/94/71/3F-Score 73/11
PEPSICO INCPEP$198.2B$145.44$93.9B$8.2B40.4%2.4112.2%0.854/96/93/71/3F-Score 56/11
Anheuser-Busch InBev SA/NVBUD$167.0B$84.81$59.3B$6.8B7.8%0.8426.0%0.721/91/93/71/3F-Score 72/11
DIAGEO PLCDEO$56.6B$101.59$28.0B$2.5B22.9%2.1415.5%1.631/94/92/71/3F-Score 45/11
Keurig Dr Pepper Inc.KDP$49.5B$36.34$16.6B$2.1B8.1%0.6321.5%0.642/92/92/71/3F-Score 62/11
AMBEV S.A.ABEV$42.5B$2.76$16.1B$2.8B17.6%0.0426.4%0.961/95/96/73/3F-Score 64/11
CONSTELLATION BRANDS, INC.STZ$24.6B$145.61$9.1B$1.7B20.9%1.2729.8%1.081/92/92/71/3F-Score 55/11
BROWN FORMAN CORPBF-B$14.1B$30.65$3.9B$715.0M17.8%0.6125.5%3.245/96/92/71/3F-Score 75/11